NEW YORK, January 7, 2026 /PRNewswire/ — Vithe AI powering healthcare companies that serve more than 190 million people, today announced the release of three State of AI 2026 reports: Health care, BiopharmaceuticalAnd Well-being. These three industry reports provide one of the most comprehensive analyzes to date of how AI is moving from experimentation to enterprise infrastructure in the global health economy.
The reports synthesize data from industry research, emerging technology architectures, and Vi’s work in healthcare companies. In all three sectors, a clear trend emerged: AI has moved beyond predictive insights and now functions as an execution layer, identifying friction, triggering interventions, and completing multi-step workflows autonomously.
In Health careAgentic AI now orchestrates and executes end-to-end operational workflows previously coordinated by entire support teams, accelerating the reduction of care gaps, reducing administrative burden, and improving patient activation. Early adopter report 10-20% higher planning response, 20-50% off in case of no-showAnd 30-40% increase in documentationwhile core models improve reasoning across clinical journeys and revenue cycle workflows. By 2028, more than 80% of common workflows can be exploited by AI.
In BiopharmaceuticalAI is becoming the operational layer of business, medical and clinical functions. For organizations deploying multi-agent orchestration, see 10 to 35% improvement in HCP activation, Evidence synthesis 2 to 3 times faster, Increased grip by 15-30%And 10 to 20% reduction in registration times. Native AI testing, automated scientific reasoning, and real-time medicine engagement redefine lifecycle performance.
In Well-beingAI has become the operational layer, moving the category from static programs and engagement heuristics to continually adaptive systems where every plan, touchpoint, and behavioral nudge is dynamically optimized. Report on platforms leveraging agent systems 3-6x improvement on core KPIs, Churn rate reduced by 20-50%, 40-60% less support loadand measurable biometric improvements such as +18% deep sleep duration.
“Our industry is moving from experimenting with AI to leveraging it,” said Omri Yoffe, CEO of Vi. “Leaders are implementing AI workflows around intelligence that can predict, decide, and act – at scale.”
“At Vi, we believe that data and know-how should serve the industry and not sit on a shelf. We’ve organized this information so that operators, researchers, and managers can actually use it in their daily work. We will continue to make them accessible across our platforms and initiatives, and if there is a question or specific use case you would like to explore, please do not hesitate to contact us.
About VI
Vi’s Enterprise AI platform helps leading healthcare organizations drive measurable performance and better healthcare outcomes. Our platform transforms the way businesses activate, engage and operate — transform data science into tangible patient and business ROI through Transparent, privacy-friendly and seamlessly integrated AI orchestration layer.
Today, Vi has a real impact on a national scale:
- 190 million patients and members supported to achieve healthier results
- More than $2 billion in measurable value generated for healthcare, pharmacy and wellness customers
- 50+ Life-Changing Therapies advanced in the fields of oncology, pediatric epilepsy, diabetes, etc.
Vi enables healthcare companies to deliver accuracy, speed and operational excellence with AI they can trust, measure and scale securely.
Headquartered in New York with teams in Tel Aviv, Boston, Austin and Nashville, Vi remains committed to leveraging technology and data science to help people live better, healthier lives.
For more information:
For more information and to access the “State of AI in Biopharma Report,” “State of AI in Healthcare Report,” and “State of AI in Wellbeing Report 2026,” visit Vi
Media Contact:
E-mail: (email protected)
Log in with Vi enabled LinkedIn for the latest updates and information.
SOURCE Vi Labs

